In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis

Stroke

Volumn 27, Issue 6, 1996, Pages 1099-1104

  Nishimura, Hiroyuki ^a   Naritomi, Hiroaki ^b   Iwamoto, Yasumichi ^a   Tachibana, Hisao ^a   Sugita, Minoru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

aspirin; endothelium; gerbils; thrombosis; ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; IBUDILAST; TICLOPIDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; GERBIL; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0029950027     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.6.1099     Document Type: Article

References (21)

1. Buchanan MR, Bastid E. Endothelium and underlying membrane reactivity with platelets, leukocyte and tumor cells: regulation by the lipoxygenase-derived fatty acid metabolites, 13-HODE and HETES. Med Hypotheses. 1988;27:317-325.
2. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
3. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977;8:301-316.
4. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia, part II: surgical group. Stroke. 1978; 9:309-319.
5. The CATS Group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215-1220.
6. The Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501-507.
7. Rosenblum WI, Nelson GH, Povlishock JT. Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. Circ Res. 1987;60:169-176.
8. Nishimura H, Nelson GH, Rosenblum WI. Chicago sky blue and a helium neon laser abolish endothelium dependent relaxation in vivo in the microcirculation. Microcirc Endothelium Lymphatics. 1989;5:435-440.
9. Gotoh F, Koto A, Tanaka K, Suzuki N, Uematsu D, Kawamura J, Yamawaki T. Rheological behavior of platelets in situ in middle cerebral artery occlusion. In: Hartmann A, Kuschinsky W, eds. Cerebral Ischemia and Hemorrheology. New York, NY: Springer-Verlag; 1987:222-232.
10. 111In-labeled platelet study. Stroke. 1993;24:1534-1540.
11. Futrell N, Riddle JM. The ultrastructure of photochemically induced thrombi with embolization in rat model. Stroke. 1993;24: 1983-1991.
12. Nishimura H, Naritomi H, Suzuki M, Takaichi S, Tachibana H, Sugita M. Experimental model of endothelial injury of common carotid artery and subsequent thrombosis in Mongolian gerbils. In: Tomita M, Mchedlishvili G, Rosenblum WI, Heiss WD, Fukuuchi Y, eds. Microcirculatory Stasis in the Brain. Tokyo, Japan: Elsevier Science; 1993:227-234.
13. Acheson J, Danta G, Hutchinson EC. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J. 1969;1:614-615.
14. Candelise L, Landi G, Perrone P, Bracchi M, Brambilla G. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke. 1982;13:175-179.
15. The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
16. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325:1261-1266.
17. A Swedish Cooperative Study. High-dose acetylsalicylic acid after cerebral infarction. Stroke. 1987;18:325-334.
18. 2 and prostacyclin. Stroke. 1992;23: 1400-1403.
19. Ohashi M, Ohkubo H, Kito J, Nishino K. A new vasodilator 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation. Arch Int Pharmacodyn Ther. 1986;283:321-334.
20. Ohashi M, Kudo Y, Ichikawa Y, Nishino K. Anti-thrombotic effect of KC404, a novel cerebral vasodilator. Gen Pharmacol. 1986;17: 385-389.
21. Ohashi M, Kito J, Nishino K. Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery. Arch Int Pharmacodyn Ther. 1986;280:216-229.